Metriopharm
  • en
  • de
MetrioPharm AG
  • Home
  • About us
    • Our Company
    • Management and Board
    • Career
  • Technology
    • MetrioPharm Platform
    • Mechanism of Action
    • Scientific Publications
  • Pipeline
    • Indications
    • Patent Protection
  • Investors
    • IR-News
    • Financial Reports and Downloads
    • Annual General Meeting
  • Press
    • Press Releases
    • Corporate Calendar
  • Contact
    • Contact form
    • Privacy policy
    • Imprint
  • en
  • de
  1. Home
  2. Investors
  3. Financial Reports and Downloads

Financial Reports and Downloads

MetrioPharm AG Annual Report 2021

MetrioPharm AG Annual Report 2021


Valuation Report (Leverage Experts)

MetrioPharm AG - Valuation (March 2021)


Regulatory Documents

Statutes of MetrioPharm AG (August 2021, German only)


Securities Information Sheet 

Securities Information Sheet in accordance to § 3a Securities Prospectus Act (German only)


Archive

MetrioPharm AG Annual Report 2020

MetrioPharm AG Annual Report 2019

MetrioPharm AG  Annual Report 2018

MetrioPharm AG Annual Report 2017

Investor Relations

Investor Relations News QIV 2022 - 2022-Dec-22

Holiday Greetings from CEO Thomas Christély

» more

Please find our corporate slide-deck as download here:
» MetrioPharm corporate slide-deck

 

The iMPact project is one of six initiatives selected by the European Commission to work on drug candidates for the treatment of SARS-CoV-2. The project includes the conduct of a Phase II clinical trial with MetrioPharm's lead compound MP1032 against COVID-19.
» iMPact Homepage

Newsletter Subscription

Subscribe to our press releases with the
MetrioPharm PR newsletter

Investors can subscribe to our quaterly corporate information with the
MetrioPharm IR newsletter

Navigation

  • Home
  • About us
  • Technology
  • Pipeline
  • Investors
  • Press
  • Contact

Social

        

Newsletter

Subscribe to our press releases with the
MetrioPharm PR newsletter

Investors can subscribe to our quaterly corporate information with the
MetrioPharm IR newsletter

Switzerland (HQ)

MetrioPharm AG

Europaallee 41
8004 Zurich

Phone: +41 44 552 7190

Germany (R&D)

MetrioPharm Deutschland GmbH

Am Borsigturm 100
13507 Berlin

Phone: +49 30 3384 395 02

  • © 2023 MetrioPharm AG
  • Imprint
  • Privacy policy (We don’t collect cookies)
  • Sitemap